Egerton Capital

After a pretty good year, Gilead Sciences, Inc. (NASDAQ: GILD) is down significantly since the start of the week. The tumble was set in motion after Express Scripts Holding Company (NASDAQ: ESRX), the largest pharmacy benefits manager in the United States, selected AbbVie Inc (NYSE: ABBV) over...